Delhi High Court Refuses Interim Relief to Johnson & Johnson’s JNTL Over ORSL Drink Ban

The Delhi High Court refused to pass any interim orders allowing JNTL Consumer Health (the Indian subsidiary of American healthcare giant Johnson & Johnson), to sell its stock of ORSL Electrolyte Drink, worth nearly Rs. 100 Crore.

The Court upheld the FSSAI directive prohibiting beverages from using misleading ORS labels, noting that such branding could deceive diarrhoea patients into mistaking them for medical oral rehydration solutions.

Rejecting JNTL’s plea, the Bench recorded that the company had already halted production and intended to rebrand the product.